Anatomic Pathology Track and Trace Solutions Market Forecasts to 2028 – Global Analysis By Technology (RFID, Barcode), Product (Consumables, Hardware, Software), End User (Hospital Laboratories, Other End Users) and By Geography
According to Stratistics MRC, the Global Anatomic Pathology Track and Trace Solutions Market is accounted for $518.45 million in 2020 and is expected to reach $1,320.80 million by 2028 growing at a CAGR of 12.4% during the forecast period. The benefits of automatic labeling solutions, rising number of legal cases of cancer misdiagnose and growing number of diagnostic tests are driving the market growth. However, high implementation cost is hampering the growth of the market.
Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions. The track and trace solutions are used to keep track of a specimen’s journey throughout the testing process. Anatomic pathology specimens, slides tracking and blocks are helping to improve the laboratory efficiency, and for the betterment of patient care, and promotion of patient safety.
Based on the product, the software segment is going to have lucrative growth during the forecast period due to the growing adoption of cloud-based LIMS and the growing need to automate the sample labeling process for reducing manual errors, increasing focus on improving the efficiency of anatomic laboratories, and the increasing workload in anatomic pathology laboratories.
By geography, North America is going to have high growth during the forecast period due to the rising incidence of chronic diseases, increasing volume of diagnostic tests in anatomic pathology laboratories, the declining number of pathologists, and presence of key vendors are contributing to the market growth in this region
Some of the key players profiled in the Anatomic Pathology Track and Trace Solutions Market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., General Data Healthcare Inc., Primera Technology, Inc., AP Easy Software Solutions, Zebra Technologies Corporation, Leica Biosystems, LigoLab, Ventana Medical Systems and Cerebrum Corporation.
Estimated Market Size in 2020:
USD 518.45 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 1,320.80 million
Tables, Graphs & Figures
Product, Technology, Application, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Radiofrequency Identification (RFID)
• Tissue Cassettes & Blocks Tracking
• Slides Tracking
• Specimen Tracking
End Users Covered:
• Independent and Reference Laboratories
• Hospital Laboratories
• Other End Users
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Anatomic Pathology Track and Trace Solutions Market is majorly driven by the increasing benefits of automatic labeling solutions, rising number of legal cases of cancer misdiagnose and growing number of diagnostic tests.
The software segment is growing at a highest CAGR due to the growing adoption of cloud-based LIMS and the growing need to automate the sample labeling process for reducing manual errors.
North America dominated with a significant market share due to the rising incidence of chronic diseases, increasing volume of diagnostic tests in anatomic pathology laboratories in the region.
Asia Pacific market is growing at a highest CAGR due to the increasing healthcare spending, higher government expenditure on security equipment in the region and rising awareness about the use of anatomic pathology tests among physicians.
Key players in Anatomic Pathology Track and Trace Solutions Market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., General Data Healthcare Inc., Primera Technology, Inc., AP Easy Software Solutions, Zebra Technologies Corporation, Leica Biosystems, LigoLab, Ventana Medical Systems and Cerebrum Corporation.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.